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Developmental and cancer biologists have long pondered 
how cell proliferation is restricted, first during embryogen-
esis to allow morphogenesis and later in adults to main-
tain homeostasis. I use the term “restricted,” rather than 
“promoted” because, although it is often assumed that 
cells must be stimulated to proliferate, the basal state of 
the single-celled eukaryotes that gave rise to metazoa was 
almost certainly one of proliferation, limited only by nutri-
ents. With the arrival of multicellularity came the require-
ment that cells acquire characteristics akin to cooperation 
and altruism, such as the ability to restrain their growth and 
division in response to signals from other cells and to die 
when no longer needed. These properties are essential for 
proper development and for maintaining homeostasis in 
adults. Acquiring them necessitated the establishment of 
new mechanisms to allow cells to sense their density or 
numbers and to apply this information to regulate intrinsic 
cellular processes including growth, division, and survival. 
Although it is clear that genetic systems controlling cell 
numbers are vulnerable (consider cancer as an example), 
we are still far from understanding how these systems oper-
ate during normal development. In this review, I highlight 
some recent advances relevant to this puzzle.
A New Signaling Complex
The advent of modern methods for generating genetic 
mosaics in the fruit fly Drosophila melanogaster (Xu and 
Rubin, 1993) prompted screens in which clones of cells 
with mutations in random genes were produced, and 
the adults were scored for abnormal tumor-like growths. 
These screens identified many genes that, when mutated, 
caused the inappropriate proliferation of cells. Many of 
these genes turned out to be orthologs of known or sus-
pected human tumor-suppressor genes, such as PTEN or 
TSC2. Studies of these genes in Drosophila have proven 
useful for assigning functions to the proteins they encode 
and mapping their signaling pathways. Some new growth 
suppressors were also discovered. The first of these was 
warts/large tumor suppressor (wts/lats), a kinase of the 
nuclear Dbf-2-related (NDR) family (Justice et al., 1995; Xu 
et al., 1995). Cells with mutations in the wts gene exhibit 
dramatic outgrowths in a variety of fly epithelial tissues but 
do not display overt changes in cell identity or the ability to 
differentiate. Further screens isolated three other genes—
hippo (hpo), salvador (sav), and mob as tumor suppressor 
(mats)—that gave strikingly similar tumorous phenotypes 
when clonally deleted in developing eyes, wings, or legs of 
the fly (Harvey et al., 2003; Kango-Singh et al., 2002; Pan-
talacci et al., 2003; Tapon et al., 2002; Udan et al., 2003; 
Wu et al., 2003, Lai et al., 2005).
The similarities among the phenotypic effects caused by 
mutations in these four genes suggested that they might 
function in a common pathway. When deleted in wing 
epithelial cells, each of them causes a cell shape change 
termed apical hypertrophy, in which the apical cell surface 
expands away from the nucleus, taking on a domed shape, 
and areas of apical-lateral adhesion are reduced (Justice et 
al., 1995). These apical-lateral regions are where adherens 
junctions reside in insect epithelia, suggesting that this set 
of genes affects the function of adherens junctions (Bilder, 
2004; Perez-Moreno et al., 2003). Clones of mutant cells 
produced in the wing or eye primordia (called “discs”) also 
exhibit smooth borders and a rounded shape, indicative of 
altered cell adhesion, although cell polarity and organization 
of the epithelial monolayer are maintained. Prior to differ-
entiation, the mutant cells were also observed to grow and 
divide more rapidly than normal cells, without any change in 
cell size. A distinct effect was noted in the eye, where muta-
tions in hpo, sav, or wts each cause inappropriate prolifera-
tion and survival of nonneural interommatidial cells just after 
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differentiation. This sug-
gested a common function 
for these genes during eye 
development (see Figure 
1). Normally, interomma-
tidial cells are produced in 
excess, and most of them 
are culled in a wave of 
apoptosis during eye dif-
ferentiation. In hpo, sav, or 
wts mutants, these interom-
matidial cells fail to die but 
instead divide several extra 
times, causing expansion 
and some disorganization 
of the eye. Mutations in the 
mats gene were reported 
to cause a somewhat more 
severe phenotype, in which 
differentiation was abro-
gated and, perhaps as a 
result, substantial apoptosis 
occurred at late stages (Lai 
et al., 2005). When very large 
cell clones with mutations in 
wts or hpo were produced, 
however, they too showed 
pronounced defects in cell 
differentiation (Wu et al., 
2003; Xu et al., 1995), sug-
gesting that the severe phe-
notype conferred by mats
mutations may not actually 
reflect a distinct function. 
The cause of these differentiation defects is unclear, but 
given that they vary according to clone size, they could be 
due to the failure of the mutant cells to effectively transduce 
long-range differentiation signals.
Given these similarities in mutant phenotypes, perhaps 
it is not surprising that the Hippo and Sav proteins were 
found to physically interact with each other, as were the 
Warts and Mats proteins (see Figure 2). Biochemical assays 
showed that Hippo, a Ste-20/MST2 type kinase, phos-
phorylates and activates Warts and that Sav, a WW-repeat 
protein, facilitates this reaction potentially by acting as a 
scaffold. Furthermore, Mats was found to bind to Warts, 
but not to Hippo, and to stimulate Warts kinase activity. 
Genetic tests performed in vivo supported these interac-
tions. Mats has also been shown to physically and geneti-
cally interact with another NDR-family kinase, tricornered
(trc), which is required for the morphogenesis of epidermal 
hairs, bristles, and dendrites (He et al., 2005). This might 
explain the relative severity of the mats mutant phenotype.
Downstream of Hippo and Warts
Targeted searches for downstream effectors revealed that 
the loss of hpo, sav, wts, or mats caused a cell-autono-
mous increase in the amounts of the Drosophila inhibitor 
of apoptosis gene product, 
DIAP-1, and the cell cycle 
regulator Cyclin E (Harvey 
et al., 2003; Pantalacci 
et al., 2003; Tapon et al., 
2002; Udan et al., 2003; 
Wu et al., 2003). DIAP-1 
and Cyclin E are important 
regulators of cell survival 
and cell cycle progression, 
respectively, and thus they 
probably account, at least 
in part, for the survival 
and continued proliferation 
of cells with mutations in 
these genes. Other poten-
tial clues to function have 
come from studies of the 
mammalian Warts ortho-
logs, LATS1 and LATS2/
Kpm, which implicate both 
proteins in the regulation of 
mitosis. LATS1 and LATS2/
Kpm are phosphorylated 
and activated in mitosis, 
and when overexpressed 
they can bind to and inhibit 
the mitotic kinase Cdk1 
(Tao et al., 1999; Yang et 
al., 2001; Xia et al., 2002; 
Kamikubo et al., 2003; Iida 
et al., 2004). This suggests 
a possible explanation for 
LATS-dependent growth 
suppression. Perhaps more importantly, loss-of-function 
studies revealed that cells lacking LATS1 or LATS2 exhibit 
defects in exiting mitosis (Bothos et al., 2005) and in cytoki-
nesis (Yang et al., 2004; McPherson et al., 2004) that lead to 
multinucleate cells, centrosome amplification, and genomic 
instability. Functions in mitosis or cytokinesis might contrib-
ute to the tumor-suppressor activity of the LATS genes in 
mammals (Takahashi et al., 2005; St. John et al., 1999), 
but such defects do not provide a ready explanation for the 
increased cell growth and survival seen in wts mutant cells 
in Drosophila. Moreover, as mitotic defects have not been 
observed in fly cells with mutations in wts, hpo, sav, or mats, 
these functions may be specific to the mammalian LATS1
and LATS2 genes.
Thus, despite the intriguing overgrowth phenotypes 
conferred by loss of genes encoding Hippo complex com-
ponents, Hippo has until recently remained an orphan 
signaling entity, lacking known upstream inputs and, for 
the most part, critical downstream effectors. Given that 
the Hippo and Warts complexes could not easily be slot-
ted into any known signaling pathway, it was assumed 
that they must define a new signaling pathway impor-
tant for containing proliferation, at least in epithelial cells. 
Although the increase in Cyclin E and DIAP-1 may explain 
Figure 1. Scanning Electron Micrographs Demonstrating 
the Overgrowth Phenotypes Conferred by Mutations in the 
Merlin/Hippo/Yorkie Pathway in Drosophila melanogaster
(A) A normal fly thorax.
(B) A tumorous outgrowth of the thorax caused by clonal deletion of 
merlin and expanded. 
(C—E) The crystalline arrangement of cells in the pupal retina (C) is 
similarly disrupted by overproliferation and inappropriate survival of in-
terommatidial cells in hippo (D) and merlin expanded (E) mutant retinas. 
Cell boundaries revealed using anti-Dlg antibodies. Images courtesy of 
Georg Halder.
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the boost in cell numbers seen in mutant tissues, these 
two target molecules cannot explain the stimulation of cell 
growth (increased cell mass) or the intriguing cell shape 
and adhesion defects displayed by these cells. Moreover, 
how the Warts kinase complex controls even its known tar-
gets (cyclin E, diap-1) is not obvious, with some research-
ers suggesting transcriptional control and others favoring 
regulation at the protein level. Two recent papers have 
redrawn this lonely scene, adding a downstream effector 
(Huang et al., 2005), some upstream inputs (Hamaratoglu 
et al., 2005), and an interesting feedback loop.
The downstream effector, Yorkie (Yki), was discovered 
by Duojia “DJ” Pan’s group not by phenotypic screens in 
flies but by virtue of its ability to bind to Warts in a yeast two-
hybrid screen (Huang et al., 2005). Yorkie is the Drosophila
ortholog of YAP (Yes-associated protein), which has been 
characterized as a non-DNA binding transcriptional coacti-
vator in mammalian cells (Yagi et al., 1999). Yorkie fulfills 
all of the criteria required of a Warts effector: it not only 
binds to Warts but appears to recapitulate all of its tumor-
suppressor functions when overexpressed in cell clones 
in developing wings and eyes of the fly. Moreover, loss-of-
function mutations in yki arrest cell growth and are epistatic 
for hpo and wts, meaning that hpo, yki, or wts, yki double-
mutant cells grow just as poorly as yki single-mutant cells. 
This suggested that the Hippo/Sav and Warts/Mats com-
plexes might act upstream of Yorkie as negative regulators, 
and indeed, they were shown experimentally to suppress 
transcriptional activation by Yorkie. Biochemical analysis 
of cultured Drosophila cells showed that Yorkie is phos-
phorylated by Warts in a Hippo/Sav-dependent fashion, 
suggesting that Warts normally suppresses Yorkie activity 
by phosphorylating it. The specific role, if any, that phos-
phorylation plays in regulating the activity of Yorkie remains 
to be determined.
The discovery of Yorkie is a substantial advance because 
it will allow the identification of the binding partners that 
bring it to the promoters of target genes. This will facilitate 
the comprehensive cataloging of Hippo/Warts targets that 
are regulated transcriptionally. Given the near-complete 
phenocopy of wts, hpo, and sav mutant phenotypes by 
overproduced Yorkie, this may cover most of the relevant 
targets and thus explain the cell adhesion, cell shape, and 
growth effects of the pathway, which are presently mysteri-
ous. The study from Huang et al. (2005) may provide the 
means to answer other pressing questions about the Hippo 
pathway. For instance, it has been suspected that Hippo/
Warts activity may increase as cells differentiate, thereby 
suppressing proliferation and promoting apoptosis, but so 
far there has been little evidence that the pathway is subject 
to spatiotemporal regulation at the onset of differentiation. 
Despite the observation that it has more profound effects 
in differentiating cells than proliferating ones, and in some 
cell types (interommatidial) than others (photoreceptors), 
all Hippo pathway components appear to be uniformly 
expressed during the stages of eye development when 
the mutant phenotypes unfold. Assays of Yorkie activity, 
most likely using phosphospecific antibodies but potentially 
based on Yorkie nuclear localization or yki reporter gene 
expression, may reveal how the Hippo pathway is regulated 
in space and time during development.
Such studies are likely to uncover considerable complex-
ity, as evidenced by a striking recent report showing that 
Warts, Hippo, and Sav play a second role as essential regu-
lators of photoreceptor cell type choice in the postmitotic 
Drosophila eye (Mikeladze-Dvali et al., 2005). In this case, 
the transcriptional targets, which might again be regulated 
by Yorkie, are rhodopsin genes essential for color vision 
and have no apparent relevance to growth suppression. 
This suggests that Yorkie probably activates distinct sets 
of genes using different DNA binding partners and that its 
spectrum of targets will vary greatly according to develop-
mental stage and cellular context. Interestingly, Mikeladze-
Dvali et al. (2005) also found that wts transcript expression 
correlated with photoreceptor cell type and was regulated 
by a conserved pleckstrin-homology (PH) domain-contain-
ing protein, Melted, in a bistable loop in which Melted and 
Warts can mutually repress each other at the transcriptional 
level. This loop ensures that photoreceptors express either 
Melted and one rhodopsin isoform (rh5, used for shorter 
wavelength colors) or Warts and a different rhodopsin iso-
form (rh6, used for longer wavelength colors), to guarantee 
that no cells express both rhodopsins simultaneously. Inter-
actions between melted and wts, or cell type-specific tran-
scription of wts, have not yet been noted during the growth 
phase in the eye or other organs.
Up the Nile
This leads us to another mystery that has dogged research-
ers in this field for several years: what are the upstream 
inputs that regulate the Hippo/Warts pathway, if it is regu-
lated? Again, to the chagrin of the fly geneticists, forward 
genetic screens gave few clues. A candidate gene approach 
taken by Georg Halder’s group, however, recently provided 
a lead that should help to focus the search (Hamaratoglu et 
al., 2005). This study followed up on earlier work (McCart-
ney et al., 2000) that showed that cells doubly mutant for 
two genes that encode band 4.1 superfamily proteins, mer-
lin and expanded, exhibited epidermal outgrowths similar 
to those caused by loss of hpo, wts, or sav. merlin and 
expanded encode members of the ezrin/radixin/moesin 
(ERM) family of FERM domain-containing proteins. They 
are partially redundant for function and can form heterodi-
meric complexes. Both proteins localize adjacent to adhe-
rens junctions and are thought to link transmembrane pro-
teins to the actin cytoskeleton (Bretscher et al., 2002; Sun 
et al., 2002; McClatchey and Giovanni, 2005). expanded
mutants exhibit mild overgrowth phenotypes in flies (Boed-
igheimer et al., 1997; Boedigheimer and Laughon, 1993), 
and mammalian fibroblasts and endothelial cells lacking 
Merlin, encoded by the neurofibromatosis 2 (NF2) tumor-
suppressor gene, are resistant to contact inhibition of pro-
liferation (Lallemand et al., 2003; Okada et al., 2005). Inter-
estingly, Lats2 mutant mouse embryonic fibroblasts also 
exhibit this defect (McPherson et al., 2004), suggesting 
that LATS2 may act downstream of Merlin in mammals as 
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its ortholog, Warts, does in Drosophila (see below).
In flies, the overgrowth phenotype of merlin, expanded
double-mutant cells is much more severe than that caused 
by either single mutant. Notably, the double-mutant phe-
notype is strikingly similar to that conferred by loss of wts, 
hpo, or sav (see Figure 1). When generated in the Drosoph-
ila eye, merlin, expanded double-mutant cells grow into 
smooth-bordered clones that proliferate inappropriately 
during the differentiation phase and then evade the normal 
wave of apoptosis that culls excess interommatidial cells. 
As with hpo and wts complex mutants, merlin, expanded
double-mutant cells also sustain increased transcription of 
cyclin E and diap-1. Hamaratoglu et al. (2005) went on to 
use a clever battery of epistasis tests to show that hpo
and wts are required for and act genetically downstream 
of merlin and expanded in containing growth and culling 
excess interommatidial cells at differentiation. For instance, 
overexpressed expanded promoted apoptosis but was 
incapable of doing so in hpo mutant tissue. Biochemi-
cal tests indicated that Merlin and Expanded do not bind 
directly to Hippo, Sav, or Warts; however, they do stimulate 
the phosphorylation of Warts by Hippo and thereby prob-
ably activate Warts to signal downstream. Consistent with 
this notion, transcriptional activation by Yorkie was shown 
to be suppressed by high levels of Merlin and Expanded. 
How these ERM proteins stimulate the interaction between 
Hippo and Warts is still unclear. Intermediate factors are 
likely involved, but the general implication is that the Hippo 
and Warts kinases communicate cues reflecting cell struc-
ture, emanating from Merlin and Expanded, to the nucleus 
via Yorkie (see Figure 2).
Searching for the Source
Although the control of the Hippo complex by ERM family 
proteins extends the pathway upstream a step, the exact 
source of the input signals is still murky. Merlin can heterodi-
merize with Ezrin (in humans) or Expanded (in Drosophila), 
and it has been reported to bind numerous factors that have 
potential functional relevance. These include cytoskeletal 
actin, β-catenin, βII-spectrin, phosphatidylinositol (4,5)-bis-
phosphate (PIP2), paxillin, and several transmembrane pro-
teins such as (in humans) CD44, a receptor for the extra-
cellular matrix component hyaluronic acid (Sun et al., 2002; 
McClatchey and Giovanni 2005). Most of these binding 
capabilities reside in the FERM domain of Merlin, which is 
highly conserved in metazoa and distinct from those of other 
ERM family members (Golovnina et al., 2005). ERM proteins 
including Merlin can switch between open (unfolded) and 
closed (self-binding) states dependent upon phosphoryla-
tion, protein-protein interactions, and mutations such as 
those in the human Merlin/NF2 gene that cause neurofibro-
matosis. This conformational change is believed to deter-
mine Merlin’s interactions with its binding partners, and it is 
the closed, hypophosphorylated conformation that appears 
to exert growth-suppressive activity. Levels of hypophos-
phorylated Merlin increase upon loss of adhesion in cultured 
(NIH 3T3) cells, and levels of both the hypo- and hyperphos-
phorylated protein increase dramatically when such cells 
become confluent, or are deprived of serum growth factors 
(Shaw et al., 1998). These changes are assumed to accom-
pany increased Merlin activity since they are associated with 
growth arrest. Similar changes in the growth suppressive 
activity of Merlin have not yet been described in differentiat-
ing tissues in vivo but will be very interesting to look for.
The aforementioned findings have suggested that Merlin 
might integrate growth stimulatory and inhibitory signals 
from transmembrane receptors like CD44 and the EGFR 
or adhesion molecules such as the cadherins (Sun et al., 
2002; McClatchey and Giovanni 2005), but so far the func-
tional data to support this attractive hypothesis is some-
what limited. Of note are studies performed in fibroblasts 
and endothelial cells showing that Merlin acts in a mutually 
antagonistic loop with p21-activated kinase (PAK) and its 
activator, the small GTPase Rac (Shaw et al., 2001; Okada 
et al., 2005). Merlin phosphorylation is Rac and PAK depen-
dent, whereas the cortical localization (and presumed 
activity) of Rac can be suppressed by Merlin. Of particular 
significance is the observation that activated forms of PAK 
or Rac can release human endothelial cells from contact 
inhibition, just as does loss of Merlin activity (Lallemand et 
al., 2003), and that an activated variant of Merlin can block 
this effect. Since Rac activity can be stimulated by growth 
factors via integrins and receptor tyrosine kinases, several 
authors have suggested that Merlin activity is suppressed 
by such signals, at least at low cell density. At high cell den-
Figure 2. The Emerging Hippo Pathway
Parts of two epithelial cells are shown, with Merlin (Mer) and Expanded 
(Ex) interacting with plasma membrane proteins (identity unknown) and 
the actin cytoskeleton and transducing a signal that stimulates the phos-
phorylation of Warts (Wts), which is in a complex with Mats (Mob as 
tumor suppressor), by Hippo (Hpo), which is in a complex with Salvador 
(Sav). Activated Warts phosphorylates and inhibits the transcriptional 
coactivator Yorkie (Yki), thereby suppressing cell growth and prolifera-
tion and allowing programmed cell death. merlin and expanded are also 
targets of Hippo signaling, creating a growth-suppressive feedback loop. 
Not all reported physical interactions or phosphorylations are shown.
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sities, however, the growth suppressive activity of Merlin is 
dominant to mitogenic signaling, and thus it is difficult to 
view Merlin as a simple signal transduction component.
Alternative mechanisms, in line with the traditional view 
that ERM proteins form a structural linkage between trans-
membrane components and the actin cytoskeleton, are 
also interesting to consider (McClatchey and Giovanni, 
2005). Such alternatives do not necessarily require spe-
cific ligands or receptors as regulators of Merlin/Expanded 
function. In one scenario, Merlin and Expanded may act as 
structural components or regulators of cell structure—pos-
sibly compromising plasma membrane-cytoskeletal cross-
linking when absent—and this would be sensed by the 
Hippo complex. This possibility seems consistent with the 
rounded cell-clone morphologies observed in Drosophila
(Hamaratoglu et al., 2005) and the observation that Merlin 
is essential for the maintenance of adherens junctions in 
mouse embryonic fibroblasts (Lallemand et al., 2003).
If Merlin and Expanded act as structural components, 
then numerous other regulators of cell adhesion and the 
cytoskeleton might also be expected to affect Hippo/Warts 
activity. Among the more intriguing genes to consider are 
the Src protooncogene, which encodes for a non-recep-
tor tyrosine kinase, and its negative regulator encoded 
by C-Src kinase (csk). The literature implicating Src as a 
regulator of cell adhesion and actin cytoskeletal function is 
vast (Frame, 2004), and both functions are consistent with 
genetic analysis in flies. Interestingly, loss of csk, which 
activates Src, causes overgrowth phenotypes in the fly eye 
that are not dissimilar to those observed in hpo, wts, or 
merlin, expanded mutants: interommatidial cells undergo 
ectopic proliferation and fail to be appropriately culled 
by apoptosis (Read et al., 2004). In this case, the effects 
downstream of Src were attributed in part to activation of 
Jun-kinase and STAT signaling, but the potential involve-
ment of the Hippo complex and Yorkie were not assessed. 
Interestingly, Nf2 mutant cells, which lack Merlin, also have 
increased Jun-kinase activity (Shaw et al., 2001).
Another plausible role for Merlin and Expanded would 
be to act as sensors of a mechanical property, such as 
tension, at the membrane-cytoskeleton interface. In this 
capacity, they might provide a means for the Hippo com-
plex to monitor cell-cell contact or adhesion. Growth sup-
pression by cell-cell contact is of course well known in cell 
culture, and, as mentioned above, Merlin, Rac, and LATS2 
mediate this response in several cell types (Lallemand et al., 
2003; McPherson et al., 2004; Okada et al., 2005). Though 
it is unclear whether contact inhibition is a useful concept 
for understanding how cell proliferation is contained during 
differentiation in vivo, the possibility is intriguing to consider. 
Developmental biologists sometimes assume that specific 
ligands and receptors must be used to arrest cell prolifera-
tion upon differentiation, but in fact there are few known 
signals that can be classified as dedicated differentiation 
signals. In Drosophila, signals that are used for patterning 
in early development (such as EGFR ligands, BMPs, Wnts, 
Notch ligands) are used again to drive differentiation (see 
for example, Firth and Baker [2005]). As part of their job 
as promoters of differentiation and morphogenesis, these 
signals cause profound changes in cytoskeletal organiza-
tion, cell adhesion, cell shape, and polarity. Hence, it may 
not be unreasonable to consider structural changes, such 
as increased adhesion or a stabilized cytoskeletal configu-
ration, as the proximal trigger for cell cycle arrest upon dif-
ferentiation. Merlin and Expanded might be used to sense, 
or orchestrate, these structural changes.
A Homeostat for Cell Structure?
In their studies of merlin and expanded, Hamaratoglu et al. 
(2005) discovered another intriguing phenomenon. They 
show that loss of hpo or wts causes a robust upregulation 
of Merlin and Expanded protein expression. This was attrib-
uted to increased levels of transcription, and thus (though 
it remains to be tested) the obvious expectation is that it is 
mediated via increased Yorkie activity. This negative feed-
back loop probably explains why loss of merlin upregulates 
expanded expression (McCartney et al., 2000) and so may 
explain how Merlin and Expanded complement each oth-
ers’ function. The potential impact of this feedback loop 
on cytoarchitecture and growth control is especially inter-
esting to consider. Although the Drosophila studies have 
not yet detailed the effects of Merlin or Expanded on cell 
structure, expanded mutant wings do show evidence of 
altered cell shape (Boedigheimer et al., 1993), and studies 
of human Merlin indicate that it can alter adhesion, motil-
ity, and actin cytoskeletal morphology (Sun et al., 2002; 
Lallemand et al., 2003; McClatchey and Giovanni 2005). If 
Merlin and Expanded were to act as both sensors of and 
regulators of cell structure, then feedback via Hippo signal-
ing could generate a closed loop, or homeostat, that might 
maintain some critical cytoarchitectural parameter (such 
as plasma membrane-cytoskeletal tension) at an optimum. 
For example, decreased plasma membrane-cytoskel-
etal tension could suppress Hippo signaling and thereby 
enhance cell growth and survival, but also upregulate Mer-
lin. The increased Merlin activity would then reestablish 
tension and activate Hippo signaling, rendering the growth 
response transient. Hence, the outlines of a mechanism of 
tissue homeostasis, as used in wound healing or contact 
inhibition, begin to emerge.
Hippo and Us
Drosophila researchers refer to hpo, sav, wts, and mats
as “tumor suppressors” and have proposed that they 
will have a similar function in humans. Indeed, the com-
ponents of this pathway are all well conserved, and some 
of the interactions observed in flies have been validated 
in mammalian cells. MST2 (Hippo) for instance, can acti-
vate LATS1 (Warts) (Chan et al., 2005), and human Mats 
homologs (the MOB proteins) have been found to associ-
ate with multiple NDR type kinases homologous to Warts 
(Tamaskovic et al., 2003). The evolutionary conservation is 
underscored by the demonstration that the human LATS1,
MATS1, MST2, and YAP genes can all functionally rescue 
their respective Drosophila mutants in vivo. Therefore, 
it seems that the basic outlines of the pathway as deter-
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mined in flies will be conserved in humans. It is still unclear, 
however, whether the mammalian Yorkie ortholog, YAP, 
will account for the majority of LATS function, as Yorkie 
appears to do for Warts. YAP has been reported to work as 
a cofactor for a variety of human transcriptional regulators, 
including P73, P53BP-2, Runx2, SMAD7, ErbB4, PEBP2α, 
and hnRNPU, but the relevance of these to LATS or MST2 
function is unknown. It is also puzzling that some of the 
described functions of YAP are opposite to those of Yor-
kie; for instance, YAP can promote apoptosis after DNA 
damage as a cofactor for P73 (Basu et al., 2003; Strano 
et al., 2001), whereas Yorkie is clearly an apoptosis sup-
pressor in the fly eye. Furthermore, the potential connec-
tion between human Merlin and the LATS/MST2 complex 
remains wholly unexplored, as does the possibility that Rac 
and PAK regulate Warts/Hippo and LATS/MST2 signaling 
in flies and humans, respectively.
As suggested by the Drosophila mutant phenotypes, a 
number of the mammalian genes in this emerging path-
way have already been associated with tumorigenesis, 
with varying degrees of confidence. These include Lats1
and Lats2 (St. John et al., 1999; Takahashi et al., 2005), 
hMats1, and Sav1/WW45 (Tapon et al., 2002). NF2/Mer-
lin, however, is the only one of these genes that is clearly 
causal for a human disease, neurofibromatosis, charac-
terized by benign tumors of the central nervous system 
(McClatchey and Giovanni 2005). Determining whether the 
others are important tumor suppressors, regulators of tis-
sue organization that lack cancer-promoting capability, or 
regulators of a completely disparate process such as color 
vision (Mikeladze-Dvali et al., 2005) will require that more 
stringent in vivo tests be performed in mice, similar to the 
mosaic knockouts done in Drosophila. Even if these genes 
prove not to be tumor suppressors in humans, they are 
likely to play important roles in preventing benign dystro-
phic diseases and ensuring normal cell and tissue archi-
tecture in developing epithelial organs.
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